Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 406

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The angiotensin–converting enzyme gene family: genomics and pharmacology

Turner, Anthony J, Hooper, Nigel M·2002·Trends in Pharmacological Sciences
DOI 10.1016/s0165-6147(00)01994-5
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0165-6147(00)01994-5

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 62

  1. Inagami, 1994, The renin–angiotensin system, Essays Biochem., 28, 147
  2. Dinh, 2001, Angiotensin receptors: distribution, signalling and function, Clin. Sci., 100, 481, 10.1042/CS20000263 · DOI
  3. Erdös, 1999, Potentiation of bradykinin actions by ACE inhibitors, Trends Endocrinol. Metab., 10, 223, 10.1016/S1043-2760(99)00156-3 · DOI
  4. Tipnis, 2000, A human homolog of angiotensin converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase, J. Biol. Chem., 275, 33238, 10.1074/jbc.M002615200 · DOI · Paper page
  5. Donoghue, 2000, A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9, Circ. Res., 87, e1, 10.1161/01.RES.87.5.e1 · DOI · Paper page
  6. Skeggs, 1956, The preparation and function of the hypertensin-converting enzyme, J. Exp. Med., 103, 295, 10.1084/jem.103.3.295 · DOI · Paper page
  7. Esther, 1997, The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice, J. Clin. Invest., 99, 2375, 10.1172/JCI119419 · DOI · Paper page
  8. Hooper, 1987, Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane, Biochem. J., 247, 85, 10.1042/bj2470085 · DOI
  9. Oppong, 1993, Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane, Biochem. J., 292, 597, 10.1042/bj2920597 · DOI
  10. Yang, 1970, A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin, Biochim. Biophys. Acta, 214, 374, 10.1016/0005-2795(70)90017-6 · DOI · Paper page
  11. Skidgel, 1985, Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone, Proc. Natl. Acad. Sci. U. S. A., 82, 1025, 10.1073/pnas.82.4.1025 · doi:10.1073/pnas.82.4.1025
  12. Soubrier, 1988, Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning, Proc. Natl. Acad. Sci. U. S. A., 85, 9386, 10.1073/pnas.85.24.9386 · DOI · Paper page
  13. Ehlers, 1989, Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme, Proc. Natl. Acad. Sci. U. S. A., 86, 7741, 10.1073/pnas.86.20.7741 · DOI · Paper page
  14. Hubert, 1991, Structure of the angiotensin I converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene, J. Biol. Chem., 266, 15377, 10.1016/S0021-9258(18)98626-6 · DOI · Paper page
  15. Jaspard, 1993, Differences in properties and enzymatic specificities between the two active sites of angiotensin I-converting enzyme. Studies with bradykinin and other natural peptides, J. Biol. Chem., 268, 9496, 10.1016/S0021-9258(18)98378-X · DOI · Paper page
  16. Rousseau, 1995, The haemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme, J. Biol. Chem., 270, 3656, 10.1074/jbc.270.8.3656 · doi:10.1074/jbc.270.8.3656
  17. Liu, 2001, Arg1098 is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity, J. Biol. Chem., 276, 33518, 10.1074/jbc.M101495200 · doi:10.1074/jbc.m101495200
  18. Wei, 1992, The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors, J. Biol. Chem., 267, 13398, 10.1016/S0021-9258(18)42224-7 · DOI · Paper page
  19. Perich, 1992, Two binding-sites on angiotensin-converting enzyme: evidence from radioligand binding studies, Mol. Pharmacol., 42, 286
  20. Parvathy, 1997, Angiotensin-converting enzyme secretase is inhibited by zinc metalloprotease inhibitors and requires its substrate to be inserted in a lipid bilayer, Biochem. J., 327, 37, 10.1042/bj3270037 · DOI
  21. Parvathy, 1998, Alzheimer's amyloid precursor protein α-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase, Biochemistry, 37, 1680, 10.1021/bi972034y · DOI
  22. Hooper, 1997, Membrane protein secretases, Biochem. J., 321, 265, 10.1042/bj3210265 · DOI · Paper page
  23. Moss, 1997, Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α, Nature, 385, 733, 10.1038/385733a0 · DOI · Paper page
  24. Hooper, 2000, Protein processing mechanisms: from angiotensin-converting enzyme to Alzheimer's disease, Biochem. Soc. Trans., 28, 441, 10.1042/0300-5127:0280441 · doi:10.1042/0300-5127:0280441
  25. Parvathy, 1998, The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-α convertase, FEBS Lett., 431, 63, 10.1016/S0014-5793(98)00726-1 · DOI
  26. Sadhukhan, 1999, Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor-necrosis factor-α-converting enzyme-deficient mice, J. Biol. Chem., 274, 10511, 10.1074/jbc.274.15.10511 · doi:10.1074/jbc.274.15.10511
  27. Ramchandran, 1995, Cleavage processing of angiotensin-converting enzyme by a membrane-associated metalloprotease, Biochemistry, 34, 12645, 10.1021/bi00039a021 · DOI
  28. Woodman, 2000, Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites, Biochem. J., 347, 711, 10.1042/0264-6021:3470711 · DOI
  29. Cushman, 1999, Design of angiotensin-converting enzyme inhibitors, Nat. Med., 5, 1110, 10.1038/13423 · DOI · Paper page
  30. Menard, 2001, Angiotensin-converting enzyme inhibitors, Adv. Protein Chem., 56, 13, 10.1016/S0065-3233(01)56002-7 · DOI
  31. Williams, 1994, Identification of two active site residues in human angiotensin I-converting enzyme, J. Biol. Chem., 269, 29430, 10.1016/S0021-9258(18)43897-5 · DOI
  32. Vendrell, 2000, Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties, Biochim. Biophys. Acta, 1477, 284, 10.1016/S0167-4838(99)00280-0 · DOI · Paper page
  33. Lee, 1994, Carboxypeptidase Taq, a thermostable zinc enzyme, from Thermus aquaticus YT-1: molecular cloning, sequencing, and expression of the encoding gene in Escherichia coli, Biosci. Biotechnol. Biochem., 58, 1490, 10.1271/bbb.58.1490 · doi:10.1271/bbb.58.1490
  34. Katugampola, 2002, Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart, Clin. Sci., 102, 15, 10.1042/CS20010092 · doi:10.1042/cs20010092
  35. Wright, 1997, Important role for angiotensin III and IV in the brain renin–angiotensin system, Brain. Res. Rev., 25, 96, 10.1016/S0165-0173(97)00019-2 · DOI · Paper page
  36. Reaux, 2001, Angiotensin III: a central regulator of vasopressin release and blood pressure, Trends Endocrinol. Metab., 12, 157, 10.1016/S1043-2760(01)00381-2 · DOI
  37. Mustafa, 2001, Characterization of the AT4 receptor in a human neuroblastoma cell line (SK-N-MC), J. Neurochem., 76, 1679, 10.1046/j.1471-4159.2001.00166.x · doi:10.1046/j.1471-4159.2001.00166.x
  38. Hamilton, 2001, A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat, Peptides, 22, 935, 10.1016/S0196-9781(01)00405-3 · DOI
  39. Albiston, 2001, Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase, J. Biol. Chem., 276, 48623, 10.1074/jbc.C100512200 · DOI · Paper page
  40. Moeller, 1997, The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain, J. Neurochem., 68, 2530, 10.1046/j.1471-4159.1997.68062530.x · DOI
  41. Roks, 1999, Angiotensin-(1–7) is a modulator of the human renin–angiotensin system, Hypertension, 34, 296, 10.1161/01.HYP.34.2.296 · DOI · Paper page
  42. Kohara, 1991, Angiotensin-(1–7): a member of circulating angiotensin peptides, Hypertension, 17, 131, 10.1161/01.HYP.17.2.131 · DOI
  43. Allred, 2000, Pathways for angiotensin-(1–7) metabolism in pulmonary and renal tissue, Am. J. Physiol., 279, F841
  44. Iyer, 2000, Contribution of angiotensin-(1–7) to blood pressure regulation in salt-depleted hypertensive rats, Hypertension, 36, 417, 10.1161/01.HYP.36.3.417 · doi:10.1161/01.hyp.36.3.417
  45. Davie, 1999, Effect of angiotensin-(1–7) and bradykinin in patients with heart failure treated with an ACE inhibitor, Hypertension, 34, 457, 10.1161/01.HYP.34.3.457 · DOI
  46. Wilsdorf, 2001, Angiotensin-(1–7) does not affect vasodilator or TPA responses to bradykinin in human forearm, Hypertension, 37, 1136, 10.1161/01.HYP.37.4.1136 · DOI
  47. Drummer, 1988, Formation of angiotensin-II and other angiotensin peptides from [des-Leu-10]-angiotensin-I in rat lung and kidney, Biochem. Pharmacol., 37, 4327, 10.1016/0006-2952(88)90614-4 · doi:10.1016/0006-2952(88)90614-4
  48. Deddish, 1998, N-domain specific substrate and C-domain inhibitors of angiotensin converting enzyme, Hypertension, 31, 912, 10.1161/01.HYP.31.4.912 · DOI · Paper page
  49. Abdalla, 2001, The angiotensin II AT2 receptor is an AT1 receptor antagonist, J. Biol. Chem., 276, 39721, 10.1074/jbc.M105253200 · DOI · Paper page
  50. Marceau, 1998, The B1 receptors for kinins, Pharmacol. Rev., 50, 357
  51. Turner, 1987, Purification and characterization of a peptidyl dipeptidase resembling angiotensin converting enzyme from the electric organ of Torpedo marmorata, J. Neurochem., 48, 910, 10.1111/j.1471-4159.1987.tb05603.x · doi:10.1111/j.1471-4159.1987.tb05603.x
  52. Isaac, 1999, Insect angiotensin-converting enzyme—a processing enzyme with broad substrate specificity and a role in reproduction, Ann. New York Acad. Sci., 897, 342, 10.1111/j.1749-6632.1999.tb07904.x · doi:10.1111/j.1749-6632.1999.tb07904.x
  53. Isaac, 1998, A novel peptide-processing activity of insect peptidyl-dipeptidase A (angiotensin I-converting enzyme): the hydrolysis of lysyl-arginine and arginyl-arginine from the C-terminus of an insect prohormone peptide, Biochem. J., 330, 61, 10.1042/bj3300061 · DOI
  54. Isaac, 1999, Hydrolysis by somatic angiotensin-I converting enzyme of basic dipeptides from a cholecystokinin/gastrin and a LH-RH peptide extended at the C-terminus with Gly-Arg/Lys-Arg, but not from diarginyl insulin, Eur. J. Biochem., 262, 569, 10.1046/j.1432-1327.1999.00419.x · DOI
  55. Cornel, 1995, Cloning and expression of an evolutionary conserved single-domain angiotensin-converting enzyme from Drosophila melanogaster, J. Biol. Chem., 270, 13613, 10.1074/jbc.270.23.13613 · DOI
  56. Taylor, 1996, The Acer gene of Drosophila codes for an angiotensin-converting enzyme homologue, Gene, 181, 191, 10.1016/S0378-1119(96)00503-3 · DOI
  57. Houard, 1998, The Drosophila melanogaster-related angiotensin-I-converting enzymes Acer and Ance—distinct enzymic characteristics and alternative expression during pupal development, Eur. J. Biochem., 257, 599, 10.1046/j.1432-1327.1998.2570599.x · DOI
  58. Coates, 2000, Functional conservation of the active sites of human and Drosophila angiotensin I-converting enzyme, Biochemistry, 39, 8963, 10.1021/bi000593q · doi:10.1021/bi000593q
  59. Coates, 2000, Exploring the Caenorhabditis elegans and Drosophila melanogaster genomes to understand neuropeptide and peptidase function, Biochem. Soc. Trans., 28, 464, 10.1042/0300-5127:0280464 · DOI
  60. Nalivaeva, 2001, Post-translational modifications of proteins: acetylcholinesterase as a model system, Proteomics, 1, 735, 10.1002/1615-9861(200106)1:6<735::AID-PROT735>3.0.CO;2-8 · doi:10.1002/1615-9861(200106)1:6<735::aid-prot735>3.0.co;2-8
  61. Zhang, 2001, Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys, J. Biol. Chem., 276, 17132, 10.1074/jbc.M006723200 · DOI · Paper page
  62. Bralet, 2001, Vasopeptidase inhibitors: an emerging class of cardiovascular drugs, Trends Pharmacol. Sci., 22, 106, 10.1016/S0165-6147(00)01644-8 · DOI

Cited by

See all 406

Metadata

Authors
Turner, A. J., & Hooper, N. M.
Venue
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Published
2002-04
Volume
23
Issue
4
Pages
177-183
ISSN
0165-6147 (ISSN-L)
DOI
10.1016/s0165-6147(00)01994-5
OpenAlex
W1980771632
Cited by
406
References
1
FWCI
1.92
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The angiotensin–converting enzyme gene family: genomics and pharmacology. https://app.cochat.ai/papers/10.1016/s0165-6147(00)01994-5
The paper
Turner, A. J., & Hooper, N. M. (2002). The angiotensin–converting enzyme gene family: genomics and pharmacology. Trends in Pharmacological Sciences. https://doi.org/10.1016/s0165-6147(00)01994-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.